When.com Web Search

  1. Ads

    related to: breast cancer genetic screening panel results

Search results

  1. Results From The WOW.Com Content Network
  2. Breast cancer screening - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer_screening

    Mammography is a common screening method, since it is relatively fast and widely available in developed countries. Mammography is a type of radiography used on the breasts. . It is typically used for two purposes: to aid in the diagnosis of a woman who is experiencing symptoms or has been called back for follow-up views (called diagnostic mammography), and for medical screening of apparently ...

  3. MammaPrint - Wikipedia

    en.wikipedia.org/wiki/MammaPrint

    In February 2007, the U.S. Food and Drug Administration (FDA) cleared the MammaPrint test for use in the U.S. for lymph node negative breast cancer patients of all ages, ER negative or ER positive, with tumors of less than 5 cm. [19] MammaPrint can be considered as a part of standard of care disease management for early stage breast cancer and ...

  4. BRCA mutation - Wikipedia

    en.wikipedia.org/wiki/BRCA_mutation

    Compared to that, a woman with a high-risk BRCA1 mutation, if she had breast cancer screening but no prophylactic medical or surgical intervention, would have only 59% chance to reach age 70, twenty-five percentage points lower than normal. Of those women not surviving, 26% would die of breast cancer, 46% ovarian cancer, and 28% other causes. [15]

  5. New breast cancer genes found in women of African ancestry ...

    www.aol.com/news/breast-cancer-genes-found-women...

    Studies to identify genetic mutations linked with breast cancer have previously mainly focused on women of European ancestry. The new findings are drawn from more than 40,000 women of African ...

  6. Hereditary breast–ovarian cancer syndrome - Wikipedia

    en.wikipedia.org/wiki/Hereditary_breast–ovarian...

    People with BRCA1 and BRCA2 mutations are recommended to have a transvaginal ultrasound 1-2 times per year. Screening with CA-125 is also recommended.. Prophylactic salpingo-oophorectomy (removal of the ovaries and fallopian tubes to prevent cancer) is recommended at age 35-40 for people with BRCA1 mutations and at age 40-45 for people with BRCA2 mutations. [6]

  7. Variant of uncertain significance - Wikipedia

    en.wikipedia.org/wiki/Variant_of_uncertain...

    A VUS is most commonly encountered by people when they get the results of a lab test looking for a mutation in a particular gene. For example, many people know that mutations in the BRCA1 gene are involved in the development of breast cancer because of the publicity surrounding Angelina Jolie's preventative treatment. [2]

  1. Ads

    related to: breast cancer genetic screening panel results